Filters
Glucagon-like peptide 1 agonists and sodium-glucose cotransporter 2 inhibitors as a new pharmacological tool for the prevention of end-organ damage (NW25-01-00076)
-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) have been observed, however with SGLT2 inhibitor will be investigated in prediabetic models depending on sex......
Endocrinology and metabolism (including diabetes, hormones)
- 2025 - 2028 •
- 11 213 tis. Kč •
- 11 213 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2025 - 31. 12. 2028
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Complex analysis of protective actions of empagliflozin on metabolic parameters and cardiorenal damage in experimental non-diabetic hypertension (GA19-06199S)
Diabetes mellitus is among the leading causes of morbidity and mortality worldwide. New antidiabetics - gliflozins (inhibitors of sodium-glucose transporter 2) show many beneficial actions beyond their antidiabetic effects. The underlying mechanisms ...
Physiology (including cytology)
- 2019 - 2022 •
- 9 633 tis. Kč •
- 9 432 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2019 - 30. 6. 2022
Uznané náklady
Podpora ze státního rozpočtu (98%)
Poskytovatel: Grantová agentura České republiky
- 1 - 2 out of 2